Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07172893 · ClinicalTrials.gov registry record · Phase 4
A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TL
A Phase 4 study of Diabetic Foot Ulcer (DFU) and Venous Leg Ulcer (VLU), sponsored by HealthTech Wound Care.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 150
- Enrollment target
- 10
- Study locations
NCT07172893: Recruiting Phase 4 study of Diabetic Foot Ulcer (DFU) and Venous Leg Ulcer (VLU), sponsored by HealthTech Wound Care.
NCT07172893 is a Phase 4 study of Diabetic Foot Ulcer (DFU) and Venous Leg Ulcer (VLU) that is actively recruiting participants, run by HealthTech Wound Care. The registered enrollment target is 150 participants, below the 507-participant average among 13 other Diabetic Foot Ulcer (DFU) trials with a reported enrollment target (70% lower). The trial reports 10 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07172893, a Phase 4 study of Diabetic Foot Ulcer (DFU) and Venous Leg Ulcer (VLU), is actively recruiting participants, sponsored by HealthTech Wound Care.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 150 participants
- Enrollment target
- 10
- Study locations
Study Summary
The purpose of this clinical evaluation is to collect patient outcome data and evaluate the efficacy, safety and tolerability of HealthTech DermaBind TL™ in patients with chronic non-healing wounds in patients with chronic non-healing ulcers.
Primary Outcome
Size of wound will be measured using Clock method * 12 o'clock to 6 o'clock: Measure the length of the wound from the top (12 o'clock) to the bottom (6 o'clock). * 9 o'clock to 3 o'clock. Measure the width of the wound from the left (9 o'clock) to the right (3 o'clock). * Depth Measurement: Use a cotton tip applicator to measure the depth. Insert the applicator gently into the deepest part of the wound, mark the point where it meets the wound edge, and measure the length from the tip to the mar
Conditions Studied
Interventions
- BIOLOGICAL DermaBind TL
Study Locations (10)
Florida
- Midland Florida Clinical Research Center - DeLand
- Pharmakon Medical Research - Palm Beach Gardens
- Vital Medical Research - Sweetwater
North Carolina
- US Foot and Ankle Specialists-Cary Satellite Site - Cary
- US Foot and Ankle Specialists - Raleigh
Ohio
- US Foot and Ankle Specialists - Blue Ash
- Lower Extremity Institute for Research and Therapy - Boardman
Michigan
- EMbassy Research Network - Bloomfield Township
Texas
- Perfizien Clinical Research, LLC. - Houston
Virginia
- Foot and Ankle Specialists of the Mid-Atlantic - Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-12-10 |
| Est. Completion | 2027-05-21 |
| Phase | Phase 4 |
What NCT07172893 shows while recruiting
NCT07172893 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 507-participant average among 13 other Diabetic Foot Ulcer (DFU) trials with a reported enrollment target (70% lower).
The record links to 2 conditions, with Diabetic Foot Ulcer (DFU) appearing as the primary indexed condition, and to 1 intervention - of which DermaBind TL is the first listed.
NCT07172893 lists 10 locations in 6 states (Florida, North Carolina, Ohio).
Frequently Asked Questions
What is clinical trial NCT07172893 about?
NCT07172893 is a clinical study titled "A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TL". The purpose of this clinical evaluation is to collect patient outcome data and evaluate the efficacy, safety and tolerability of HealthTech DermaBind TL™ in patients with chronic non-healing wounds in patients with chronic non-healing ulcers.
What is the current status of trial NCT07172893?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2025-12-10. Estimated completion is 2027-05-21.
What conditions does trial NCT07172893 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer (DFU), Venous Leg Ulcer (VLU).
What interventions are being tested in trial NCT07172893?
The interventions under investigation include: DermaBind TL (BIOLOGICAL).
Who is sponsoring clinical trial NCT07172893?
This trial is sponsored by HealthTech Wound Care, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07172893 being conducted?
This trial has 10 study locations across Florida, Michigan, North Carolina, Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer (DFU)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07172893's enrollment target sits among peer trials
150 9th of 13 higher than 5 of 13 other Diabetic Foot Ulcer (DFU) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetic Foot Ulcer (DFU) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy
RECRUITING · Phase 4
-
Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.
RECRUITING · Phase 4
-
Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers
RECRUITING · NA
-
CARE-D-FOOT-Nav Pilot
RECRUITING · NA
-
A Prospective Clinical Study to Evaluate the Effectiveness and Safety of Xcell Amnio MatrixTM (XAM) in the Management of Chronic Non-healing DFUs
RECRUITING · NA
-
CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW Populations
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI